Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders. 2022

Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

The most common form of the disease caused by Toxoplasma gondii (T. gondii) is latent toxoplasmosis due to the formation of tissue cysts in various organs, such as the brain. Latent toxoplasmosis is probably a risk factor in the development of some neuropsychiatric disorders. Behavioral changes after infection are caused by the host immune response, manipulation by the parasite, central nervous system (CNS) inflammation, as well as changes in hormonal and neuromodulator relationships. The present review focused on the exact mechanisms of T. gondii effect on the alteration of behavior and neurotransmitter levels, their catabolites and metabolites, as well as the interaction between immune responses and this parasite in the etiopathogenesis of psychiatric disorders. The dysfunction of neurotransmitters in the neural transmission is associated with several neuropsychiatric disorders. However, further intensive studies are required to determine the effect of this parasite on altering the level of neurotransmitters and the role of neurotransmitters in the etiology of host behavioral changes.

UI MeSH Term Description Entries
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders
D014122 Toxoplasma A genus of protozoa parasitic to birds and mammals. T. gondii is one of the most common infectious pathogenic animal parasites of man. Toxoplasma gondii,Toxoplasma gondius,Toxoplasmas,gondius, Toxoplasma
D014123 Toxoplasmosis The acquired form of infection by Toxoplasma gondii in animals and man. Toxoplasma gondii Infection,Infection, Toxoplasma gondii
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
January 2023, International review of neurobiology,
Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
July 1984, Acta neurologica Scandinavica,
Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
September 1998, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR),
Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
August 2003, Journal of neuroimmunology,
Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
July 2008, Progress in neuro-psychopharmacology & biological psychiatry,
Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
September 2013, Trends in neurosciences,
Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
January 1994, Fundamental & clinical pharmacology,
Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
January 2015, Journal of acquired immune deficiency syndromes (1999),
Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
April 1977, The Medical journal of Australia,
Tooran Nayeri, and Shahabeddin Sarvi, and Ahmad Daryani
May 1996, Cognitive neuropsychiatry,
Copied contents to your clipboard!